Tag Archives: FDA

Battelle President, CEO Lou Von Thaer Receives His Fifth Wash100 Award

Lou Von Thaer President and CEO Battelle

Lou Von Thaer, president and CEO of Battelle, was presented with his 2020 Wash100 Award by Executive Mosaic for expanding the company’s revenue and influence in the government contracting (GovCon) sector through valuable contract awards, partnerships and important executive appointments. Executive Mosaic congratulates Battelle and Lou Von Thaer for his fifth Wash100 Award.

Read More »

NIH Announces New Initiative to Speed Up COVID-19 Diagnostics Development

The National Institutes of Health has launched a new initiative to accelerate the development and commercialization of testing technologies for the new coronavirus. The Rapid Acceleration of Diagnostics program will use $1.5B in federal stimulus funds to invest in efforts that work on new COVID-19 testing technologies, NIH said Thursday.

Read More »

Health Agencies, Biopharmaceutical Firms Form Partnership to Accelerate COVID-19 Vaccine Development

health-agencies-biopharmaceutical-firms-form-partnership-to-accelerate-covid-19-vaccine-development

The National Institutes of Health and three other U.S. health agencies have teamed up with the Foundation for the NIH, European Medicines Agency and 16 biopharmaceutical companies to speed up the development of vaccines and treatments for COVID-19. The Accelerating COVID-19 Therapeutic Interventions and Vaccines partnership will work to streamline clinical trials, coordinate regulatory processes and use assets to accelerate response to the coronavirus pandemic and other future health emergencies, NIH said Friday.

Read More »